sublingual tirzepatide study Is delivery the future for GLP-1 agonists? Sublingual Tirzepatide - Weight Management

U.S.-licensed clinicians on every prescription, no auto-approvals

Ive had patients tell me that after starting GLP-1 therapy, they no longer experience cravings for alcoholsomething neither they nor I expected. GLP-1s for Weight Loss: A Long-Term Commitment While GLP-1s have been beneficial for many, they are not a one-size-fits-all solution

Stapled and xenopus glucagon-like peptide 1 (GLP-1)-based dual GLP-1/gastrin receptor agonists with improved metabolic benefits in rodent models of obesity and diabetes

doi:10.1007/s00125-023-05956-x Qureshi N, Wesolowicz L, Stievater T, Lin AT

However, in vitro, evidence suggests that hyperglycemia, a primary metabolic feature of T2DM, can lead to impaired GLP-1 secretion and L-cell differentiation